Is There a Better Option Than Melatonin? 

Melatonin is the world's most popular sleep supplement, with U.S. sales rising roughly 150% between 2016 and 2020. Yet for many people taking it nightly for general insomnia, the honest answer from clinical research is: melatonin may not be the right tool for the job. Whether a better option exists depends entirely on what kind of sleep problem you actually have — and that distinction is one most supplement marketing never explains.

Table of Contents

1. 1. What Melatonin Actually Does (and Doesn't Do)
2. 2. Why Melatonin Disappoints So Many Chronic Insomniacs
3. 3. CBT-I: The Evidence-Based First-Line Treatment Most People Skip
4. 4. Magnesium: A Complementary Option With Emerging Evidence
5. 5. Sleep Hygiene: Necessary Foundation, Not a Standalone Fix
6. 6. When Melatonin Is Genuinely the Best Option
7. 7. Getting More From Melatonin: Why Form Matters
8. Frequently Asked Questions
9. Conclusion

1. What Melatonin Actually Does (and Doesn't Do)

Melatonin is not a sedative. It is a hormone produced by your pineal gland in response to darkness, functioning as a biological "time signal" that tells your brain and body it is night. When you take a melatonin supplement, you are not switching on sleep — you are advancing or reinforcing your internal clock's sense of when nighttime begins. That distinction matters enormously for understanding when melatonin helps and when it does not.

A landmark 2013 meta-analysis of 1,683 participants across 19 randomized controlled trials found that melatonin reduced sleep onset latency by 7.06 minutes and increased total sleep time by 8.25 minutes compared to placebo. These are statistically significant effects — but the authors noted that the absolute benefit is smaller than other pharmacological sleep treatments. The effects were real, modest, and they did not appear to fade with continued use.

Where melatonin shows its clearest value is in disorders involving misalignment between your internal clock and your environment. Research published in the British Journal of Pharmacology confirms that clinically meaningful effects of melatonin are best documented in circadian rhythm sleep disorders, jet lag, shift work, and delayed sleep phase syndrome (DSPS) — conditions where the body's melatonin rhythm is either suppressed or mistimed. For people whose sleep problem is not fundamentally circadian in nature, the evidence is considerably weaker.

2. Why Melatonin Disappoints So Many Chronic Insomniacs

The most important clinical finding about melatonin that almost no supplement label mentions: for adults with chronic, non-comorbid insomnia, it often does not work meaningfully. A 2022 NIH review of 12 studies involving 2,666 participants found that while melatonin helped sleep onset latency, it did not improve sleep quality or reduce time spent awake during the night — the two outcomes most chronic insomniacs actually care about. Both the American Academy of Sleep Medicine (2017) and the VA/DoD clinical guidelines (2019) explicitly recommend against melatonin as a treatment for chronic insomnia on grounds of insufficient evidence.

Why the disconnect? Chronic insomnia is rarely a melatonin deficiency problem. It is typically maintained by a self-reinforcing cycle of conditioned arousal: the more you worry about sleep, the harder you try to force it, and the harder your nervous system works against you. Melatonin adjusts your circadian clock but does nothing to break this cycle. A 2022 systematic review in Sleep Medicine Reviews, analyzing 24 RCTs with approximately 1,700 patients, found melatonin was not significantly effective for sleep onset latency, total sleep time, or sleep efficiency in non-comorbid adult insomnia.

This does not mean melatonin is useless — it means most people are using it for the wrong problem. Roughly 33–50% of adults report regular difficulty sleeping, but the reasons vary enormously. Someone with DSPS (delayed sleep phase syndrome) sleeping poorly because their clock is shifted 2–3 hours late has a fundamentally different problem from someone who lies awake with a racing mind after a stressful day. Melatonin is the right tool for the first person and likely the wrong tool for the second.

3. CBT-I: The Evidence-Based First-Line Treatment Most People Skip

If chronic insomnia is your problem, the treatment with the strongest evidence base is Cognitive Behavioral Therapy for Insomnia, or CBT-I. The American Academy of Sleep Medicine designates CBT-I as the first-line recommended treatment for chronic insomnia — ahead of any medication or supplement. It is not widely known because it requires effort and professional guidance, and because no one profits from advertising a therapy. A 2015 meta-analysis of 20 randomized controlled studies found CBT-I reduced sleep onset latency by an average of 19 minutes and time awake after sleep onset by 26 minutes — considerably larger effects than melatonin produces.

CBT-I works by targeting the actual drivers of chronic insomnia: conditioned arousal, dysfunctional sleep beliefs, and behaviors that disrupt your body's natural sleep pressure. The core components include sleep restriction (counterintuitive but highly effective), stimulus control, and cognitive restructuring. When these techniques are used together as multicomponent CBT-I, 70–80% of patients with primary insomnia experience meaningful improvements.

The other critical advantage of CBT-I over any supplement: the results last. A meta-analysis of 30 randomized controlled trials published in Sleep Medicine Reviews (2019) demonstrated that CBT-I produces clinically significant reductions in insomnia severity at 3, 6, and 12 months after treatment ends — something no sleep supplement has been shown to replicate. Melatonin must be taken every night to work; CBT-I teaches your sleep system to function better on its own. The practical limitation is access: trained CBT-I providers are not widely available, and a full course of 4–8 sessions takes weeks. Digital CBT-I programs (apps and online courses) are now a validated alternative for those without easy access to a therapist.

4. Magnesium: A Complementary Option With Emerging Evidence

Magnesium is the sleep supplement most often mentioned alongside melatonin, and for good reason — it has a plausible mechanism and growing clinical evidence. Magnesium acts as a natural NMDA receptor antagonist and GABA agonist, meaning it reduces nervous system excitation and promotes the neurological conditions that allow sleep to occur. Unlike melatonin, which targets your circadian clock, magnesium works more directly on the nervous system's capacity to settle at night.

A systematic review and meta-analysis published in BMC Complementary Medicine and Therapies (2021) pooled data from 3 randomized controlled trials in older adults with insomnia and found that magnesium supplementation reduced sleep onset latency by 17.36 minutes compared to placebo — a larger effect on this particular outcome than melatonin typically produces in comparable populations. Total sleep time also improved, though that finding did not reach statistical significance.

The honest caveat: magnesium's evidence base is smaller than CBT-I's and somewhat variable across study populations. The existing trials are predominantly in older adults, who may be more likely to be magnesium-deficient at baseline. Estimates suggest that roughly half of older adults have suboptimal magnesium status, which may explain why the effects are more pronounced in this group. If you suspect poor sleep is connected to stress, muscle tension, or a diet low in leafy greens, nuts, and seeds, magnesium is a reasonable complementary strategy to explore alongside behavioral approaches — not instead of them.

5. Sleep Hygiene: Necessary Foundation, Not a Standalone Fix

Sleep hygiene refers to the behavioral and environmental practices that support good sleep: consistent sleep and wake times, limiting caffeine after early afternoon, minimizing blue light exposure in the two hours before bed, keeping your bedroom cool and dark, and reserving your bed for sleep and sex only. These practices are not glamorous, and they are not sufficient on their own for clinical insomnia — but they are the foundation that determines how well everything else works.

The Sleep Foundation describes good sleep hygiene as "putting yourself in the best position to sleep well each and every night" and notes that improving it has virtually no cost or risk — making it a logical first step for anyone with sleep difficulties. The American Academy of Sleep Medicine clarified in a 2021 meta-analysis that sleep hygiene should not be used as a stand-alone treatment for chronic insomnia, as it alone is insufficient. It is most powerful as the behavioral framework within which CBT-I and, where appropriate, supplements like melatonin operate.

Practically speaking: no supplement performs at its best in an environment that works against sleep. A person taking BioAbsorb Liposomal Melatonin or any other sleep supplement while checking their phone in bed, drinking caffeine after 2pm, and sleeping at erratic hours is undermining the intervention at every step. Sleep hygiene does not replace targeted treatment — but skipping it guarantees that targeted treatment will underperform.

6. When Melatonin Is Genuinely the Best Option

Having examined melatonin's limitations honestly, it is equally important to be clear about when the evidence strongly favors melatonin over alternatives. For circadian rhythm disruption — situations where your body clock is misaligned with your desired sleep window — melatonin is uniquely effective and CBT-I or magnesium are not comparable substitutes. The Mayo Clinic identifies three specific conditions where melatonin has clear evidence: jet lag, delayed sleep phase syndrome (DSPS), and circadian rhythm disorders in blind individuals who cannot use light cues to anchor their clocks.

For jet lag, the evidence is particularly strong. A 2021 NIH review of 10 studies and 994 participants found that melatonin helps with jet lag after both eastbound and westbound flights. For shift workers — approximately 5–10% of whom develop clinical shift work disorder — melatonin supports daytime sleep alignment in a way that no behavioral therapy can fully replicate, because the core problem is environmental rather than psychological. Research in the British Journal of Pharmacology confirms melatonin's unique role as the body's primary time signal: exogenously administered melatonin improves circadian rhythm amplitudes and misalignments in a way that is pharmacologically specific to this function.

For older adults experiencing age-related sleep changes, melatonin also has a stronger rationale than for younger chronic insomniacs. Melatonin production declines significantly with age — some estimates suggest production in adults over 60 is 50% lower than in young adults. In this population, the evidence for melatonin's effects on sleep quality is more favorable, particularly for improving sleep onset and consolidation. The key principle: match the intervention to the mechanism. If your sleep problem is a timing problem, melatonin is often the right answer.

7. Getting More From Melatonin: Why Form Matters

If melatonin is the right tool for your sleep problem, the next question is whether you are getting an effective dose of it into your bloodstream. Standard melatonin tablets must survive digestion before absorption can occur, and the first-pass effect in the liver significantly reduces bioavailability — typically to around 15–20% for conventional tablet formulations. This means that if you take a 3mg tablet, you may only be absorbing 0.45–0.6mg. Dose-response research suggests that melatonin's effects peak at around 4mg of effective dose — making absorption efficiency directly relevant to whether you get results.

Liposomal delivery addresses this problem at the molecular level. Liposomal melatonin encases the active ingredient in a phospholipid bilayer — the same structural form as your cell membranes — allowing it to pass through the gut lining and into circulation without the degradation that tablets undergo. BioAbsorb Nutraceuticals' Liposomal Liquid Melatonin achieves 80–95% bioavailability and an onset time of 15–30 minutes, compared to 60–90 minutes for standard tablets. This faster onset makes timing more predictable and allows for lower doses to achieve equivalent effects.

BioAbsorb Nutraceuticals manufactures in a Health Canada-approved, GMP-certified Canadian facility. The liposomal liquid comes in a graduated dropper that allows doses from approximately 0.25mg to 1.5mg per full dropper — a practical advantage given that research consistently shows many people use far higher doses than the evidence supports for effectiveness. Priced at $29.99 for 100ml (100 servings), it is a cost-effective option for those for whom melatonin is the appropriate tool. Every batch is third-party tested, with a certificate of analysis available on request. Non-GMO, vegan, gluten-free, and free of artificial flavours or colours.

Frequently Asked Questions

Is melatonin safe to take every night long-term?

Melatonin is considered relatively safe for short-term use by the NIH's National Center for Complementary and Integrative Health, but its long-term safety has not been well established in large trials. The Sleep Foundation notes that for those using melatonin for a circadian-specific purpose (jet lag, shift work, DSPS), regular use during that context is reasonable — whereas for general insomnia, the better long-term strategy is CBT-I, which addresses the root cause rather than requiring nightly supplementation indefinitely.

Can I take melatonin and magnesium together?

There is no known interaction between melatonin and magnesium, and they work via distinct mechanisms — melatonin on your circadian clock, magnesium on nervous system inhibition. For individuals whose sleep problems involve both a circadian component and general nighttime restlessness or muscle tension, some practitioners consider them complementary. That said, the evidence for each is moderate, and combining supplements does not multiply their effects. Start with the intervention best matched to your specific sleep problem before layering additional supplements.

Why does melatonin work for some people and not others?

The primary reason is sleep problem type. Melatonin is most effective for people whose sleep problem is fundamentally a timing or circadian issue — jet lag, shift work disorder, DSPS, or age-related melatonin decline. For people with chronic insomnia driven by conditioned arousal, anxiety, or poor sleep habits, melatonin does little to address those drivers. Additionally, individuals vary significantly in melatonin metabolism, meaning the same 3mg dose produces very different blood levels across people — another reason that a low-dose, high-bioavailability formulation is often preferable to a standard high-dose tablet.

How do I know if CBT-I is right for me?

CBT-I is recommended for anyone who has had difficulty falling or staying asleep at least 3 nights per week for 3 months or more — the standard definition of chronic insomnia. It is also appropriate for shorter-term insomnia where psychological and behavioral factors are clearly contributing. Signs that CBT-I is likely to help include: you fall asleep easily outside of your own bed, you spend more than 30 minutes lying awake, you feel anxious specifically about sleep, or your problem began or worsened during a stressful period. A sleep medicine physician or your GP can provide a formal assessment and referral.

What dose of melatonin is most effective?

Research consistently shows that most people use more melatonin than they need. The NIH recommends starting at 0.5–1mg, taken 30–60 minutes before the desired sleep time. Dose-response analyses show that effective melatonin peaks at around 4mg of bioavailable dose — not total dose. Because standard tablets deliver only 15–20% of their labelled dose into circulation, a 3mg tablet may yield less effective melatonin than a 0.5mg liposomal formulation. Starting low and adjusting based on response is generally the most effective strategy.

Is there a situation where neither melatonin nor CBT-I is the right answer?

Yes. If insomnia is a symptom of an underlying condition — sleep apnea, restless legs syndrome, depression, chronic pain, thyroid dysfunction — neither melatonin nor CBT-I will resolve the root problem. Approximately 50% of people with chronic insomnia have a comorbid condition that contributes to or drives their sleep difficulty. Persistent insomnia that does not respond to behavioral approaches and has no clear trigger warrants evaluation by a physician to rule out underlying causes before continuing with supplement strategies.

Conclusion

There is no single "better option" than melatonin — there is only the right option for your specific sleep problem. For chronic insomnia driven by conditioned arousal and learned behaviors, CBT-I outperforms melatonin by a wide margin and its effects last long after treatment ends. For circadian disruption — jet lag, shift work, DSPS, or age-related melatonin decline — melatonin remains the most targeted and evidence-supported tool, particularly when delivered in a high-bioavailability form. If you have determined that melatonin is appropriate for your situation, explore BioAbsorb's Liposomal Liquid Melatonin — a formulation that ensures you actually absorb the dose you take, with the precision dosing and purity that effective melatonin use requires.

Research References

1. Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. PLOS ONE, Vol. 8 (2013). Pooled 19 RCTs and 1,683 participants; found melatonin reduced sleep onset latency by 7.06 minutes and increased total sleep time by 8.25 minutes vs. placebo, supporting use for primary sleep disorders with a modest but consistent effect.
2. Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses. Sleep Medicine Reviews, Vol. 66 (2022). Analyzed 24 RCTs; found melatonin was not significantly effective for sleep onset latency, total sleep time, or sleep efficiency in non-comorbid adult chronic insomnia, informing AASM recommendation against its use for this indication.
3. Cognitive Behavioral Therapy for Insomnia: A meta-analysis of long-term effects in controlled studies. Sleep Medicine Reviews, Vol. 48 (2019). Meta-analysis of 30 RCTs demonstrating CBT-I produces clinically significant insomnia reductions at 3, 6, and 12 months after treatment; effects persist without ongoing intervention.
4. A Systematic Review and Network Meta-Analysis Evaluating Melatonin, Light Exposure, Exercise, and CAM for Insomnia Disorder. Journal of Sleep Research, Vol. 29 (2020). Network meta-analysis of 40 studies; found melatonin effective for sleep onset (large objective effect) but small subjective effect; confirmed CBT-I as first-line recommendation.
5. Oral magnesium supplementation for insomnia in older adults: A Systematic Review and Meta-Analysis. BMC Complementary Medicine and Therapies, Vol. 21 (2021). Meta-analysis of 3 RCTs; found magnesium reduced sleep onset latency by 17.36 minutes vs. placebo; noted low-to-moderate quality of evidence requiring further trials.
6. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. British Journal of Pharmacology, Vol. 175 (2018). Review confirming melatonin's clinically meaningful effects are best documented in disorders of misaligned or diminished melatonin rhythms — circadian disorders, jet lag, shift work, and DSPS.
7. Melatonin: What You Need To Know. National Institutes of Health — National Center for Complementary and Integrative Health (2022). NIH overview of melatonin safety, dosage, and evidence base; notes 150% sales increase 2016–2020 and summarises AASM/VA/DoD recommendations against melatonin for chronic insomnia.
8. Sleep Disorders and Complementary Health Approaches. National Institutes of Health — National Center for Complementary and Integrative Health (2023). Comprehensive NIH review of complementary approaches for sleep; summarises 2022 review finding melatonin did not improve sleep quality or wake time during the night in chronic insomnia populations.
9. Cognitive Behavioral Therapy for Insomnia: An Effective and Underutilized Treatment for Insomnia. Current Psychiatry Reports, Vol. 21 (2019). Review of CBT-I evidence base; found 70–80% of primary insomnia patients experience improvements with multicomponent CBT-I; characterizes CBT-I as effective and equivalent to sleep medication without the side effects.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.